NCT04336241 2026-02-27Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsReplimune Inc.Phase 1 Active not recruiting36 enrolled
NCT04180371 2025-11-17Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionBicycleTx LimitedPhase 1/2 Active not recruiting288 enrolled